Mansa-X Under the Microscope: Seven Hard Questions, the Facts Behind Them and the Disclosures Investors Still Deserve

Mansa‑X has emerged as one of the most significant investment products in East Africa, both in terms of scale and visibility. By mid‑2026, assets under management across its Kenya‑shilling and US‑dollar funds had reached KES 184.32 billion, a level that naturally attracts scrutiny. Yet scrutiny, when met with transparency and evidence, can strengthen investor confidence rather than weaken it. The fund’s record, mandate, and governance framework demonstrate that Mansa‑X is not only delivering returns but also operating within a disciplined and regulated structure designed to safeguard investors.

Performance is the most visible measure of any investment product, and Mansa‑X’s record is both consistent and verifiable. The Kenya‑shilling fund has delivered an average annualised net return of 18.37% from January 2019 to June 2026. The US‑dollar fund, launched in November 2022, has achieved 12.51% over the same period. Interim results for the first half of 2026 showed net returns of 10.97% for the KES fund and 6.54% for the USD fund. If sustained, these would equate to annualised rates of 23.15% and 13.51% respectively.

Historical data reinforces this picture. Between 2019 and 2025, the KES fund reported annual net returns ranging from 15.45% to 20.74%. The USD fund, though younger, reported 12.10% in 2023, 12.50% in 2024, and 13.37% in 2025. A KES 1 million investment made in January 2019 was valued at KES 3.59 million by March 2026 after fees, while a USD 10,000 investment in November 2022 had grown to USD 14,949. These figures, supported by audited statements, demonstrate a multi‑year record that is both testable and reconcilable. They confirm that performance is not a one‑off windfall but the result of a repeatable strategy.

Figure 1. Reported annual net returns for the KES and USD funds. H1 2026 is shown as an actual six-month return, not an annual return. The dotted lines mark the manager-reported since-inception annualised averages to 30 June 2026.

Read Also: Mansa-X Special Fund Maintains Dominance, Commanding 73.5% Of The Special CIS Market Share Per CMA Report

Mansa‑X is not a conventional money‑market fund. It is a special collective investment scheme with a global, multi‑asset, long‑short mandate. Its portfolio may include currencies, listed equities, stock indices, sovereign fixed income, commodities, precious metals, derivatives, and cash across major international markets. This breadth of mandate is the source of both its return potential and its complexity.

The fee structure reflects this sophistication: a 5% annual financial‑services charge, prorated daily, and a 10% performance fee on returns above a 25% hurdle for the KES fund and 15% for the USD fund. There are no initial or redemption fees, but a six‑month lock‑in applies. These terms are transparent and aligned with the nature of the strategy. They also highlight why Mansa‑X should not be compared directly with money‑market funds, where strategies, risks, fees, and liquidity terms are materially different.

The umbrella structure of the fund has occasionally prompted questions about cross‑liability between sub‑funds. In practice, each sub‑fund maintains independent mandates, accounting records, portfolios, unitholders, and net asset values. Management and reporting are carried out separately, and no sub‑fund’s assets have ever been used to settle another’s liabilities. While the trust deed does contain a cross‑liability provision, the operational reality is one of separation and discipline. Investors can therefore be confident that the structure is regulated, overseen by a trustee and custodian, and subject to external audit.

Income reporting has shown that more than 80% of the two funds’ income is classified as offshore trading gains. This is consistent with the fund’s global mandate and reflects realised and unrealised positions across currencies, equity indices, commodities, sovereign fixed income, and equities. While the distinction between realised and unrealised gains is important, the broader point is that income is generated within approved investment limits and subject to board oversight.

Valuation practices follow internationally accepted standards. Instruments with observable market prices are marked to quoted values, while those without active quotations are valued using recognised methods overseen by management, trustee, and auditor. Daily unit prices are published, ensuring transparency. This framework provides investors with confidence that valuations are credible and independently verified.

Risk management is embedded in the fund’s operations. Position exposures and liquidity limits are continuously monitored against predetermined thresholds, and scenario analysis forms part of the investment process. Stress testing is conducted to evaluate sensitivities to currency moves, interest‑rate shocks, equity declines, commodity gaps, and liquidity squeezes. These practices ensure that the fund is resilient across multiple market conditions.

Counterparty exposure is managed under IFRS 9’s expected‑credit‑loss framework. Trading is restricted to approved counterparties selected for financial strength, operational capacity, and regulatory standing. Exposure is monitored continuously, and impairment is recognised on a forward‑looking basis. This approach ensures that credit risk is addressed proactively rather than reactively.

Revenue recognition has been identified as a key audit matter, reflecting the complexity of multi‑market trading systems and large transaction volumes. Importantly, the auditor issued an unqualified opinion on the financial statements as a whole. This confirms that revenue recognition and valuation processes meet professional standards. The designation of a key audit matter signals heightened auditor attention, not adverse findings.

The distinction between audited and non‑audited commentary is also important. Factsheets and trustee reports provide timely interim data, but audited statements remain the definitive source. Investors can be confident that audited information is reliable, while non‑audited commentary serves as supplementary explanation.

Mansa‑X operates under the oversight of the Capital Markets Authority (CMA). It has a licensed manager, trustee, custodian, and external auditor. These safeguards are substantive and provide a strong foundation for investor confidence. They ensure that the fund is not only delivering returns but also operating within a regulated governance framework.

Taken together, the evidence demonstrates that Mansa‑X is a professionally managed, well‑regulated, and transparent investment product. Its performance record is consistent, its mandate is sophisticated, and its governance framework is robust. Operational safeguards, valuation practices, risk management, and audit assurance all contribute to a structure that is credible and disciplined.

While no investment can eliminate risk, Mansa‑X offers investors a serious and well‑governed vehicle for global market exposure. Its multi‑year track record, regulatory oversight, and transparent operations provide a solid basis for confidence. Investors can therefore approach Mansa‑X with assurance that it is designed to deliver returns within a clear and regulated framework, combining strong historical performance with robust governance.

Confidence in Mansa‑X is not built on marketing claims or defensive responses. It is built on evidence: audited performance, regulated structure, disciplined risk management, and transparent reporting. These elements together confirm that Mansa‑X is a credible investment product, worthy of its scale and visibility, and positioned to continue serving investors with professionalism and integrity.

Read Also: Mansa-X H1 2026: The Fund Turning Market Discipline Into Double-Digit Investor Returns